Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.52 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | PDE4A | P27815 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1416528 | 0.89 | RECQL (0.51) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL27700906 | 0.86 | ACHE (0.55) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL2761089 | 0.86 | ACHE (0.55) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL28869338 | 0.86 | ACHE (0.55) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL1416644 | 0.86 | RECQL (0.62) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL1416500 | 0.86 | RECQL (0.62) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Sulfuric Acid SCHEMBL3005563 | 0.86 | ACHE (0.63) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL1715389 | 0.84 | ACHE (0.61) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Sulfuric Acid SCHEMBL21195033 | 0.84 | ACHE (0.61) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL3005599 | 0.84 | HTT (0.54) | RAD52KMT2ASMN1; SMN2HSP90AA1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | claimed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | claimed |
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | disclosed |
| US-7897806-B2 | Reacting primary amines with phosgene in ionic liquid as solvent | BASF AKTIENGESELLSCHAFT (DE) | 2011-03-01 | — | — | US | disclosed |
| US-20100191010-A1 | PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 | HUNTSMAN INTERNATIONAL LLC (US) | 2010-07-29 | — | — | US | disclosed |
| EP-2173705-A1 | PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 | Huntsman International LLC (US) | 2010-04-14 | — | — | EP | disclosed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | disclosed |
| WO-2009013062-A1 | PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 | HUNTSMAN INTERNATIONAL LLC (US) | 2009-01-29 | — | — | WO | disclosed |
| EP-2011782-A1 | Process for the synthesis of carbamates using co2 | HUNTSMAN INTERNATIONAL LLC (US) | 2009-01-07 | — | — | EP | disclosed |
| EP-1812382-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006048171-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | PGLS, INMT, PNMT | ACHE 796/4885CHRM2 2669/4885ADRA2A 3286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.